These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128 [TBL] [Abstract][Full Text] [Related]
23. Temozolomide in patients with high grade gliomas. Brandes AA; Pasetto LM; Vastola F; Monfardini S Oncology; 2000 Sep; 59(3):181-6. PubMed ID: 11053983 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy in the treatment of high grade gliomas. Lonardi S; Tosoni A; Brandes AA Cancer Treat Rev; 2005 Apr; 31(2):79-89. PubMed ID: 15847978 [TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954 [TBL] [Abstract][Full Text] [Related]
29. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093 [TBL] [Abstract][Full Text] [Related]
30. [Pattern of care of high-grade gliomas]. Laigle-Donadey F; Sanson M Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503 [TBL] [Abstract][Full Text] [Related]
31. Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide. Kaloshi G; Sierra del Rio M; Ducray F; Psimaras D; Idbaih A; Laigle-Donadey F; Taillibert S; Houillier C; Dehais C; Omuro A; Sanson M; Delattre JY; Hoang-Xuan K J Neurooncol; 2010 Dec; 100(3):439-41. PubMed ID: 20464625 [TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506 [TBL] [Abstract][Full Text] [Related]
33. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Chamberlain MC Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470 [TBL] [Abstract][Full Text] [Related]
34. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy. Valeriani M; Ferretti A; Franzese P; Tombolini V Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628 [TBL] [Abstract][Full Text] [Related]
35. Effects of palliative treatment with temozolomide in patients with high-grade gliomas. Ziobro M; Rolski J; Grela-Wojewoda A; Zygulska A; Niemiec M Neurol Neurochir Pol; 2008; 42(3):210-5. PubMed ID: 18651326 [TBL] [Abstract][Full Text] [Related]
36. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas. Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431 [TBL] [Abstract][Full Text] [Related]
37. Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. Soritau O; Tomuleasa C; Aldea M; Petrushev B; Susman S; Gheban D; Ioani H; Cosis A; Brie I; Irimie A; Kacso G; Florian IS J BUON; 2011; 16(2):282-9. PubMed ID: 21766499 [TBL] [Abstract][Full Text] [Related]
38. [Favourable result for temozolomide in recurrent high-grade glioma]. Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692 [TBL] [Abstract][Full Text] [Related]
39. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861 [TBL] [Abstract][Full Text] [Related]
40. Current evidence of temozolomide and bevacizumab in treatment of gliomas. Nanegrungsunk D; Onchan W; Chattipakorn N; Chattipakorn SC Neurol Res; 2015 Feb; 37(2):167-83. PubMed ID: 25033940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]